Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway as Survival Biomarkers in Colorectal Cancer
Identificadores
URI: https://hdl.handle.net/10481/85009Metadata
Show full item recordAuthor
Pérez Durán, Carmen; Márquez Pete, Noelia; Gálvez Navas, José María; Cura, Yasmin; Rojo-Tolosa, Susana; Pineda-Lancheros, Laura Elena; Ramírez Tortosa, María Carmen; García Collado, Carlos; Maldonado Montoro, María del Mar; Villar Del Moral, Jesús María; Pérez Ramírez, Cristina; Jiménez Morales, AlbertoMateria
Colorectal cancer Vitamin D metabolism Survival Single nucleotide Polymorphisms Caucasian VDR CYP2R1 CYP27B1 CYP24A1 GC
Date
2023-08-12Sponsorship
ERDF funds (EU); Instituto de Salud Carlos III (PT13/0010/0039); Biobank of the University Hospital Virgen de las NievesAbstract
Several studies have suggested that single nucleotide polymorphisms (SNPs) related to
vitamin D metabolism may affect CRC carcinogenesis and survival. The aim of this study was to
evaluate the influence of 13 SNPs involved in the vitamin D metabolic pathway on CRC survival. We
conducted an observational retrospective cohort study, which included 127 Caucasian CRC patient
from the south of Spain. SNPs in VDR, CYP27B1, CYP2R1, CYP24A1, and GC genes were analyzed
by real-time polymerase chain reaction. Progression-free survival (PFS) and overall survival (OS)
were assessed. Cox regression analysis adjusted for metastasis, age of diagnosis, stage (IIIB, IV or
IVB), ECOG score (2–4), lymph node involvement, adjuvant chemotherapy, and no family history of
CRC showed that the VDR ApaI (p = 0.036), CYP24A1 rs6068816 (p < 0.001), and GC rs7041 (p = 0.006)
were associated with OS in patients diagnosed with CRC, and CYP24A1 rs6068816 (p < 0.001) was
associated with PFS adjusted for metastasis, age of diagnosis, stage (IIIB, IV or IVB), ECOG score
(2–4), lymph node involvement, adjuvant chemotherapy, and no primary tumor resection. The rest of
the SNPs showed no association with CRC survival. Thus, the SNPs mentioned above may have a
key role as prognostic biomarkers of CRC